Rashid Kazerooni
5PUBLICATIONS
3CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 25, 2025
Reply to Trosch et al. Comment on "Dashtipour et al. Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information. Toxins 2024, 16, 442".Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen
|Oct 25, 2024
Dysphagia and Muscle Weakness Secondary to Botulinum Toxin Type A Treatment of Cervical Dystonia: A Drug Class Analysis of Prescribing Information.Khashayar Dashtipour, Han S Lee, Aaron Ellenbogen
|Jul 08, 2021
Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare Systems.Rashid Kazerooni, Ileana M Howard, Adrienne M Keener
|Nov 04, 2018
Response to "Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database".Rashid Kazerooni, Edward P Armstrong
|Jun 22, 2018
Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database.Rashid Kazerooni, Edward P Armstrong
Pageof 1
